ID   HeLa PurRII7
AC   CVCL_4W41
DR   Wikidata; Q54882554
RX   PubMed=3207599;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI:17939; Puromycin.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 05-10-23; Version: 10
//
RX   PubMed=3207599; DOI=10.1038/bjc.1988.237;
RA   Gupta R.S., Murray W., Gupta R.;
RT   "Cross resistance pattern towards anticancer drugs of a human
RT   carcinoma multidrug-resistant cell line.";
RL   Br. J. Cancer 58:441-447(1988).
//